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GM1 ganglioside plays a role in essential neuronal processes, including differentiation,
survival, and signaling. Yet, little is known about GM1 species with different sphingosine
bases, such as the most abundant species containing 18 carbon atoms in the
sphingosine chain (GM1d18:1), and the less abundant containing 20 carbon atoms
(GM1d20:1). While absent in the early fetal brain, GM1d20:1 continues to increase
throughout pre- and postnatal development and into old age, raising questions about
the functional relevance of the GM1d18:1 to GM1d20:1 ratio. Matrix-assisted laser
desorption/ionization imaging mass spectrometry is a novel technology that allows
differentiation between these two GM1 species and quantification of their expression
within an anatomical context. Using this technology, we find GM1d18:1/d20:1
expression ratios are highly specific to defined anatomical brain regions in adult
rats. Thus, the ratio was significantly different among different thalamic nuclei and
between the corpus callosum and internal capsule. Differential GM1d18:1/GM1d20:1
ratios measured in hippocampal subregions in rat brain complement previous studies
conducted in mice. Across layers of the sensory cortex, opposing expression gradients
were found for GM1d18:1 and GM1d20:1. Superficial layers demonstrated lower
GM1d18:1 and higher GM1d20:1 signal than other layers, while in deep layers
GM1d18:1 expression was relatively high and GM1d20:1 expression low. By far the
highest GM1d18:1/d20:1 ratio was found in the amygdala. Differential expression of
GM1 with d18:1- or d20:1-sphingosine bases in the adult rat brain suggests tight
regulation of expression and points toward a distinct functional relevance for each of
these GM1 species in neuronal processes.
Keywords: MALDI, imaging mass spectrometry, GM1, ganglioside expression, cortex
Abbreviations: APP, amyloid precursor protein; AUC, area under curve; CA, cornu ammonis; DG, dentate gyrus; DMN,
dorsomedial nucleus of thalamus; ET-1, Endothelin-1; GC, granular cell layer; GM, monosilylated ganglioside; GD,
disialylated ganglioside; GT, trisialylated ganglioside; IMS, imaging mass spectrometry; MALDI, matrix-associated laser
desoprtion/ionization; PC, pyramidal cell layer; TG, transgenic; VPM, ventroposteriormedial nucleus of thalamus; WT,
wildtype.
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INTRODUCTION
Gangliosides are sialylated glycosphingolipids composed of
a hydrophobic ceramide base anchored within the cellular
membrane and a carbohydrate moiety that extends into
the extracellular space (Figure 1A). Gangliosides are highly
clustered within lipid rafts, specialized membrane microdomains
where signaling molecules are abundant and where the lipid
composition can greatly inﬂuence the accessibility of proteins
involved in signal transduction and cell metabolism (Sonnino
et al., 1990; Sonnino and Prinetti, 2010). It is therefore not
surprising that gangliosides are especially prominent in brain
tissue, accounting for about ten percent of the brain’s lipid mass.
Among gangliosides, GM1 is highly expressed within the brain
and is known to be involved in a number of neuronal functions,
including neuronal diﬀerentiation, survival, neurotransmission
and neuritogenesis (Posse de Chaves and Sipione, 2010; Ledeen
and Wu, 2015). Interest in GM1 has peaked in recent years for
its therapeutic potential in neurodegenerative conditions, namely
Huntington’s disease (Maglione et al., 2010; Di Pardo et al., 2012)
and Parkinson’s disease (Schneider et al., 2010). Yet, there is also
a substantial body of evidence linking GM1 to the production
of amyloid beta ﬁbrils in Alzheimer’s disease (Ueno et al., 2014;
Yanagisawa, 2015).
While most research on gangliosides in neuroscience has
focused on their carbohydrate moiety, little is known about
the relevance of diﬀerent sphingosine chain lengths, which are
not readily accessible by immunolabeling techniques. Using
chromatographic and mass spectrometric approaches, several
distinct species of GM1 have been identiﬁed based on the long
chain base of their ceramide moiety. GM1 containing 18 carbon
atoms in its sphingosine base, hereafter referred to as GM1d18:1,
is the predominant species in the brain and detectable already
in early fetal development (Rosenberg and Stern, 1966). GM1
with 20 carbon atoms in its sphingosine base, hereafter referred
to as GM1d20:1, is not detectable in early development but is
increasingly expressed during pre- and postnatal development
(Rosenberg and Stern, 1966; Sonnino andChigorno, 2000).While
GM1d18:1 remains the dominant species, aged brains show an
increase in GM1d20:1 compared to young brains (Sonnino and
Chigorno, 2000). The developmental diﬀerence in the expression
of GM1d18:1 and GM1d20:1 has recently been conﬁrmed in
the mouse hippocampus with an IMS approach similar to the
one used in this study, where a diﬀerential expression of the
two species was also evident in anatomical subregions of the
hippocampus (Sugiura et al., 2008). These ﬁndings indicate that
the expression of GM1 containing diﬀerent sphingosine bases is
regulated tightly both temporally and spatially.
While the temporal evolution of GM1d18:1/GM1d20:1 ratio
throughout development and maturation of the brain is well
described (Sonnino and Chigorno, 2000; Sugiura et al., 2008),
little is known about the spatial distribution of GM1d18:1 and
GM1d20:1 in diﬀerent brain regions, outside the hippocampus.
A novel and emerging technique, MALDI IMS can identify
GM1 species with diﬀerent ceramide moieties, and allows
quantiﬁcation of their expression within anatomical context
(Goto-Inoue et al., 2011; Whitehead et al., 2011; Ellis et al.,
2013). Using this technique, we ﬁnd GM1d18:1/GM1d20:1 ratios
are speciﬁc to anatomically distinct brain regions, suggesting
a functional relevance of the so far largely neglected ceramide
moiety of gangliosides in the brain. Our ﬁndings emphasize
that new technologies may uncover novel meaningful biological
processes that were previously unknown due to the bias in
knowledge toward what can be reliably detected with the tools
of the time.
MATERIALS AND METHODS
Procedures Involving Live Animals
All procedures involving live animals were in accordance with
the guidelines of the Canadian Council on Animal Care and
approved by the University of Western Ontario Animal Use
Committee (Protocol 2014–2016). Twenty-three female Fisher
rats, which were part of an in-house breeding colony, were used
at 8 to 10 months of age at euthanasia. These rats were part of
an experiment to answer the question whether stroke changes
ganglioside expression diﬀerentially in WT rats compared to rats
that overexpress APP (an early Alzheimer’s Disease model). As
no statistically signiﬁcant changes in ganglioside expression were
detected in any experimental group (Supplementary Figure S1),
all animals were pooled for the anatomical analyses presented
in this article. All rats were bred in house. Founder breeding
pairs were kindly provided by Dr. Yuksel Agca (University
of Missouri). Fourteen animals were homozygous TG for the
human APP gene carrying both the Swedish and Indiana
mutations (Agca et al., 2008). Eight WT and eight TG animals
received a small experimental stroke by stereotaxic injection of
3 µl saline containing 10 pmol (ET-1, Sigma–Aldrich, St. Louis,
MO, USA) into the right striatum (+0.5 mm anterior, 3 mm
lateral to bregma at 5 mm depth below the dura) 28 days before
euthanasia (Caughlin et al., 2015). The remaining one WT and
six TG animals did not undergo surgical procedures. All animals
were euthanized with an overdose of pentobarbital (Euthanyl),
brains were harvested without delay, the cerebellum removed,
and the rest of the brain was frozen on dry ice and stored at
−80◦C.
Tissue Sample Preparation
Brains were attached to a specimen holder on dry ice with
distilled water. Using a cryostat, 10 µm thick coronal brain
sections were thaw-mounted onto indium tin oxide (ITO) coated
glass slides (Hudson Surface Technology Inc., Old Tappan, NY,
USA). Slides were dehydrated for 15 min in a vacuum chamber
and then coated with 1,5-diaminonaphthalene (DAN, Sigma–
Aldrich, Oakville, ON, Canada) matrix using a sublimation
apparatus (Chemglass Life Sciences, Vineland, NJ, USA). DAN
matrix was sublimated for 9min at 130◦C sand bath temperature.
Following matrix application, a calibration mixture of ﬁve
standard proteins (4700 Calibration Mixture, AB Sciex, Concord,
ON, Canada) was mixed with alpha-cyano-4-hydroxy-cinnamic
acid matrix (CHCA, Sigma–Aldrich) and 0.75 µl spots were
applied on DANmatrix-free areas of the glass slide in the vicinity
of the section to be imaged. Once calibration spots had dried,
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FIGURE 1 | Chemical structure of GM1 d18:1 (A, top) and GM1 d20:1 (A, bottom).Mass spectra in the GM1 m/z range generated from two different
anatomical regions, the piriform cortex and the striatum, show differential expression of GM1d18:1 and GM1d20:1. (B) The spectrum shown in red has been shifted
to the right for better visualization of differences in peaks. Molecular image shows expression of GM1d18:1. For all analyses, the area under the curve (AUC) was
calculated for the highest peak of each species (arrows).
slides were stored at −20◦C overnight. The following day, glass
slides were thawed and dehydrated in a vacuum chamber for
15 min.
MALDI Imaging Mass Spectrometry
Indium tin oxide coated glass slides with sample sections were
mounted into a MALDI holding plate and inserted into a Sciex
MALDI 5800 TOF/TOF mass spectrometer (Sciex, Framingham,
MA, USA). Following calibration at 50 ppm mass tolerance,
image acquisition was started in reﬂectron and negative ion
mode, with a 70 µm laser step distance. A mass spectrum with
a 1000–2000 m/z range was acquired for each laser shot.
Analysis of Molecular Image Data
Molecular images were analyzed using Tissue View Software
(Sciex). All imageswere optimized for visualization of expression,
therefore color intensities do not reﬂect the same absolute
signal intensity across diﬀerent images. In each section, similar
regions of interests (ROIs) were drawn for each anatomical
region in the left and right hemisphere. As we cannot identify
anatomically deﬁned regions based on their cytoarchitecture
in molecular images, we selected ROIs with reference to
the Rat Brain Atlas by Paxinos and Watson (1998). The
sampled cortical regions include putative primary and secondary
somatosensory cortex (Figure 2B). The average mass spectral
data for each ROI was exported, and the baseline noise was
removed for each peak. GraphPad Prism software version 6
(GraphPad Software Inc., La Jolla, CA, USA) was used to
measure the area under the curve (AUC) to quantify the
highest peak for GM1d18:1 at a predicted m/z of 1544.87,
and for GM1d20:1 at a predicted m/z of 1572.9, respectively
(Figure 1B). Subsequently, the ratio of AUC of the highest
GM1d18:1 peak to that of the highest GM1d20:1 peak was
calculated for each ROI. Based on previous studies (Whitehead
et al., 2011; Caughlin et al., 2015) measuring the AUC for the
ﬁrst (largest) peak is indicative of total signal for all isotope
peaks of the species. Four measurements were taken for each
animal (both hemispheres in two sections), and the average
Frontiers in Neuroanatomy | www.frontiersin.org 3 December 2015 | Volume 9 | Article 155
Weishaupt et al. Differential Expression of GM1 Subspecies
FIGURE 2 | Cortical sampling areas are depicted in a histological section stained with thionine (A). Mass spectra were generated from a superficial, an
intermediate and a deep region of interest within the somatosensory cortex (B, modified from Paxinos and Watson, 1998), and corresponding regions were also
sampled in two more posterior sections per animal. GM1d18:1/GM1d20:1 ratios were significantly different (Tukey’s multiple comparisons, ∗∗∗∗p < 0.0001) among
cortical layers (C). Molecular images show the anatomical expression of GM1d18:1 (green) and GM1d20:1 (red) in the cortex (D). Scale bar = 3 mm. Dashed box
marks cortical region magnified in bottom row (E). Dashed lines in composite image mark the borders between sampling areas for different cortical layers. Scale
bar = 3 mm. All images are optimized for visualization and do not represent absolute concentrations (GM1d18:1 is the predominant species even in the superficial
layers of the cortex).
per animal was presented in graphs and used for statistical
analyses. The corpus callosum and cortical layers were sampled
in eight ROIs (in two anterior and two posterior sections,
in both hemispheres). In cases where image resolution was
insuﬃcient for detailed analysis, the average value was taken from
less than four sample measurements. Individual animal’s ROIs
with less than two measurements were excluded. Each ROI is
represented by average values from 16 to 20 brains. All calculated
GM1d18:1/GM1d20:1 ratios are available in the MetaboLights
database (MTBLS271).
Statistical Analyses
Statistical comparisons were performed using GraphPad Prism
software (GraphPad Software Inc.). Data sets were ﬁrst tested
for ﬁtting a Gaussian distribution, and based on the result,
either a t-test or a Mann–Whitney test was used to compare
two anatomical regions, and a one-way ANOVA with Tukey’s
multiple comparisons or a Kruskal–Wallis test was performed
to compare the GM1d18:1/GM1d20:1 expression ratio among
three or more anatomical regions. Bar graphs depict the
mean and the standard error of the mean (SEM), which is
also stated in the text. A p value of <0.05 was considered
signiﬁcant.
RESULTS
GM1d18:1/GM1d20:1 Ratio in Different
Experimental Conditions
In order to detect any potential diﬀerences in the
GM1d18:1/GM1d20:1 ratio between WT and TG animals,
as well as between animals that received a low-dose striatal
ET-1 injection and controls, the GM1d18:1/GM1d20:1 ratio
was plotted for all experimental groups for each region. There
was no signiﬁcant diﬀerence among the groups in any one
region analyzed here (Supplementary Figure S1), which allowed
us to pool all experimental animals to increase the power for
the anatomical study. The low variability among individual
GM1d18:1/GM1d20:1 ratios in each region was reﬂected by the
small SEMs.
Frontiers in Neuroanatomy | www.frontiersin.org 4 December 2015 | Volume 9 | Article 155
Weishaupt et al. Differential Expression of GM1 Subspecies
GM1d18:1/d20:1 Ratio within the
Cerebral Cortex
The cerebral cortex is divided into six layers based on
cellular morphology and function (Figure 2A). While individual
layers were not clearly distinguishable in molecular images, a
gradient of expression of both GM1 species analyzed across the
depth of the somatosensory cortex was observed (Figure 2B).
Superﬁcial layers had relatively low GM1d18:1 expression
and relatively high GM1d20:1 signal intensities, intermediate
layers had an intermediate signal intensity for both GM1
species, and the deep layers showed substantial GM1d18:1
expression, while lacking considerable amounts of GM1d20:1
(Figures 2C–E). When quantiﬁed, these opposing expression
gradients for both GM1 species (Figure 2E) resulted in a
signiﬁcantly lower GM1d18:1/GM1d20:1 ratio in the superﬁcial
layers (2.55 ± 0.03, n = 14) compared to deeper layers
(Tukey’s multiple comparisons, p < 0.0001, Figure 2C). In
contrast, the ratio in the deepest layers was signiﬁcantly higher
(4.43 ± 0.11, n = 14) than in all other layers (Tukey’s
multiple comparisons, p < 0.0001) and almost twice as
high as the ratio measured in superﬁcial layers (Figure 2C).
These measurements were consistent between layers of the
somatosensory cortices in sections anterior to bregma and
layers of the somatosensory cortices at about 3 mm posterior
to bregma. The average of all analyzed regions is shown
(Figure 2C). When comparing cortical areas neighboring
the sampled cortical regions to the GM1d18:1/GM1d20:1
expression pattern quantiﬁed above, it was obvious that this
is not a pattern consistent throughout all cortical areas and
layers. There were clearly visible borders to this expression
pattern, with the superﬁcial layers of the dorsal motor
cortex and the cingulate cortex expressing relatively more
GM1d18:1 than the somatosensory cortex expresses in its
superﬁcial layers (not quantiﬁed). The molecular images also
showed a strong GM1d18:1 dominance in the piriform cortex
neighboring the somatosensory cortex ventrally. The piriform
cortex, which is largely devoid of GM1d20:1, is considered
archicortex and is evolutionarily among the oldest cortical
areas.
GM1d18:1/d20:1 Ratio within Major
White Matter Tracts
The expression ratio of the two GM1 species was measured in the
corpus callosum (CC, Figure 3A) and in the internal capsule (IC,
Figure 3A). GM1 signal was so low in the white matter relative
to surrounding gray matter that meaningful images could not be
generated, however, mass spectra clearly indicated the presence of
both GM1d18:1 and GM1d20:1 within the sampled white matter
regions (Figure 3B). The average ratio of all sampling areas per
animal for the CC (5.506 ± 0.31, n = 19) was signiﬁcantly higher
than the ratio within the internal capsule (3.56 ± 0.22, n = 18,
Mann–Whitney, p< 0.0001, Figure 3C).
GM1d18:1/d20:1 Ratio within the
Hippocampus
Sampling regions for spectral analysis were considerably smaller
in hippocampal areas than in all other brain regions to limit
accidental inclusion of neighboring regions, especially when
sampling the narrow cellular layers (Figure 4A). Among the
cell layers of the DG, (4.14 ± 0.25, n = 20), CA ﬁeld 1 (CA1,
3.59 ± 0.18, n = 20) and CA ﬁeld 3 (CA3, 3.72 ± 0.21, n = 17),
there was no statistical diﬀerence in the GM1d18:1/GM1d20:1
expression (Figure 4B). However, the GC of the DG has a
slightly higher ratio than the PCs of CA1 and CA3 (Figure 4B).
In contrast, we found an extremely low GM1d18:1/GM1d20:1
ratio within the molecular layer of the DG (1.90 ± 0.06,
n = 21, Figure 4C). This layer stood out as the area of
greatest relative GM1d20:1 expression in a cross section of the
hippocampus, while GM1d18:1 expression was visibly lower in
this layer than in the neighboring stratum radiatum (Figure 4C).
The GM1d18:1/GM1d20:1 ratio within the molecular layer
of the DG is signiﬁcantly lower than the ratio within the
stratum radiatum of the CA1 (3.19 ± 0.15, n = 20) and
CA3 region (4.03 ± 0.12, n = 21, Kruskal–Wallis test, DG
vs. CA1 p < 0.001, DG vs. CA3 p < 0.0001, Figure 4B).
Careful visual examination of the GM1d20:1 expression image
(red, Figure 4C) indicated a change in expression between the
stratum radiatum in the CA1 versus the CA3 region, which
was reﬂected by a signiﬁcantly lower GM1d18:1/GM1d20:1
FIGURE 3 | A schematic cross section shows the ROIs used to generate mass spectra for the corpus callosum (CC), which was also sampled in
more anterior sections, and the internal capsule (IC, A). Mass spectrum from a representative section shows differential expression of GM1d18:1 And
GM1d20:1 in the CC and IC (B). The GM1d18:1/GM1d20:1 ratio was significantly lower in the IC than in the CC (Mann–Whitney test, ∗∗∗∗p < 0.0001, C).
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FIGURE 4 | Schematic shows the small sampling points within the hippocampus from which mass spectra were generated (A). While the cell layers
across the CA1, CA3, and DG had a similar GM1d18:1/GM1d20:1 ratio, the ratio differed significantly among the molecular layer of the DG and the stratum radiatum
in the CA1 and CA3 regions (Kruskal–Wallis test, DG vs. CA1 ∗∗p < 0.001, DG vs. CA3 ∗∗∗∗p < 0.0001, CA1 vs. CA3 ∗p < 0.05, B). CA1 pc, CA1 PC; CA1 rad,
CA1 stratum radiatum; DG gc, dentate gyrus GC; DG ml, dentate gyrus molecular layer; CA3 rad, CA3 stratum radiatum; CA3 pc, CA3 PC. Molecular images of
GM1d18:1 expression (green) and GM1d20:1 expression (red) showed high expression of the d20:1-species almost exclusively within the DG ml, while the
d18:1-species was highest within the stratum radiatum (C). Scale bar = 2 mm.
ratio in the CA1 region (Kruskal–Wallis test, p < 0.05,
Figure 4B).
GM1d18:1/d20:1 Ratio in the Thalamus
The thalamus is a highly diverse structure that oﬀers a multitude
of regions for analysis of GM1 expression. Because we can
sample areas that are visibly delineated by their GM1d18:1
or GM1d20:2 expression proﬁle with the highest conﬁdence,
we chose the DMN and the ventral posteromedial nucleus
(VPM) of the thalamus for analysis (Figure 5A). While the
DMNdemonstrated high GM1d18:1 signal intensity inmolecular
images, hardly any GM1d20:1 signal could be observed visually
(Figure 5B). Both species were expressed at relatively low levels in
the VPM, leading to a signiﬁcantly higher GM1d18:1/GM1d20:1
ratio in the DMN (4.53 ± 0.12, n = 18) versus the VPM
(3.14 ± 0.13, n = 18, Mann–Whitney test, p < 0.0001,
Figure 5C). Diﬀerential expression was also observed within
the lateral posterior thalamic nucleus (Figures 5A,B, not
quantiﬁed).
GM1d18:1/d20:1 Ratio within the
Hypothalamus and Amygdala
Based on the relative expression of both GM1 species
in molecular images, the hypothalamus had a relatively
lower content of GM1 in comparison to the thalamus, the
hippocampus, cortical regions and the amygdala (Figure 6A).
While the GM1d20:1-species was hardly visible within the
hypothalamus and amygdala, GM1d18:1 showed a markedly
higher expression within the amygdala. When quantiﬁed
(Figure 6B), GM1d18:1 expression was eight times higher
than GM1d20:1 expression in the amygdala (8.15 ± 0.29,
n = 19), the highest ratio measured in any brain region analyzed
(Figure 6C). This ratio is signiﬁcantly higher than the ratio in
the hypothalamus, where there was more than 6 times more
GM1d18:1 than GM1d20:1 (6.40± 0.33, n = 18, Mann–Whitney
test, p< 0.0001, Figure 6C).
DISCUSSION
Biological Role of the Ceramide Moiety
of Gangliosides
Studies focusing on the ceramide moiety of gangliosides in the
brain are relatively scarce, but important discoveries reported
recently point toward a functionally distinct role for these
diﬀerent ganglioside species (Sugiura et al., 2008; Whitehead
et al., 2011; Oikawa et al., 2015). Based on the biochemical
diﬀerences between d18:1- and d20:1-sphingosine molecules in
the ceramide base, it has been suggested that the diﬀerent species
inﬂuence local membrane ﬂuidity diﬀerentially, with a longer
sphingosine tail making the membrane ﬂatter and more rigid
(Sonnino and Chigorno, 2000). Membrane ﬂuidity can determine
the three dimensional environment of specialized membrane
microdomains, such as lipid rafts, ultimately inﬂuencing the
accessibility of membrane proteins and the occurrence of
protein–protein interactions (Sonnino et al., 1990). How these
biochemical features translate into biological function is at
this point not known for ganglioside GM1. Yet, GM1d18:1
and GM1d20:1 species have been found to be upregulated
after severe cerebral ischemia, each GM1 species following a
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FIGURE 5 | Sampling regions for the DMN included its lateral and medial parts, the ROI covering the VPM may also have included parts of the
VPL (A). CM, central medial thalamic nucleus; LPMR, lateral posterior thalamic nucleus, mediorostral part; MDL, mediodorsal thalamic nucleus, lateral part; MDM,
mediodorsal thalamic nucleus, medial part; VPL, ventral posterolateral thalamic nucleus; VPM, ventral posteromedial thalamic nucleus. Molecular images of
GM1d18:1 expression (green) and GM1d20:1 expression (red) showed differential expression of the two species within the DMN and VPM, as well as within the
LPMR (not quantified, B). Scale bar = 1 mm. The ratio of GM1d18:1/GM1d20:1 was significantly higher within the DMN than the VPM (Mann–Whitney test,
∗∗∗∗p < 0.0001, C).
slightly diﬀerent expression pattern in and around the infarct
(Whitehead et al., 2011). In the same study, the spatio-temporal
expression proﬁles of d18:1 and d20:1 species of GD1, GT1,
GM2, and GM3 were also speciﬁc to the sphingosine chain
length following ischemia. The biological relevance of the
ceramide moiety of gangliosides was recently conﬁrmed in a
study where the c18:0 and c20:0 fatty acid species of GD1b
were shown to have diﬀerential eﬀects on the assembly of
amyloid protein (Oikawa et al., 2015). Likewise, GM1d18:1 and
GM1d20:1 were upregulated to slightly diﬀerent degrees in a
combined model of Amyloid Beta load and striatal ischemia
(Caughlin et al., 2015). These ﬁndings, together with the unique
biochemical properties of diﬀerent sphingosine carbon chain
lengths and the tight regulation of their expression emphasize
a potential functionally meaningful role of the ganglioside
ceramide bases in health and disease of the central nervous
system.
From past investigations into the expression of the c20-
sphingosine species of gangliosides we know that the expression
of this molecule increases during development and with age.
We therefore chose a rat model that would reﬂect a mature
brain state. Aging rats to 8–10 months, which corresponds
to a young to middle-aged adult, ensures that GM1d20:1 is
substantially expressed. Brains at this level of maturity likely
reﬂect the general anatomical expression pattern of GM1d18:1
and GM1d20:1 through most of adulthood, as our ﬁndings of
hippocampal expression ratios are in line with previous reports
in mice (Sugiura et al., 2008). However, Sugiura and colleagues
found an increase in c20-sphingosine containing GD1 in the
molecular layer of the DG between 2 and 33 months old mice,
suggesting a slow but potentially continuous increase of the c20-
sphingosine species of gangliosides with age. Investigations at
more senior stages in life are needed to further our understanding
of how the GM1d18:1/GM1d20:1 ratio changes in the aging
and senescent brain, and whether various anatomical regions
undergo diﬀerent changes at diﬀerent times as the brain
ages.
Discussion of Present Findings in
Anatomical Context
In the somatosensory cortical regions analyzed, the superﬁcial
layers, which are part of a mostly corticocortical projection
network, have a distinctly lower GM1d18:1/GM1d20:1 ratio than
deeper layers. GM1d20:1 is highly expressed in superﬁcial and
intermediate layers, which are projection targets for thalamic
input (Hooks et al., 2013; Shigematsu et al., 2015). Whether
thalamic axons are a main source of GM1d20:1 in these regions
can at this point only be speculated. While our analysis was
focused on parietal cortical areas, where gradients in GM1d18:1
and GM1d20:1 expression were obvious in the molecular
images, other cortical areas seem to diverge from this pattern.
More comprehensive studies on the comparison of diﬀerent
cortical areas may address the question whether ganglioside
expression relates to the unique neuronal structures known to
exist in specialized cortical areas particularly in primates (Elston
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FIGURE 6 | Expression images of GM1d18:1 (green) and GM1d20:1 (red) showed relatively high GM1d18:1 expression within the amygdala, while
GM1d20:1 expression was low within the hypothalamus and amygdala (A). Scale bar = 4 mm. A schematic cross section shows regions included in ROIs
from which mass spectra were generated for the amygdala and hypothalamus (B). AHiAL, amygdalohippocampal area, anteriolateral part; BMP, basomedial
amygdaloid nucleus, posterior part; BLP, basolateral amygdaloid nucleus, posterior part; DM, dorsomedial hypothalamic nucleus; MePD, medial amygdaloid
nucleus, posterodorsal part; MePV, medial amygdaloid nucleus, posteroventral part; PeF, perifornical nucleus; PH, posterior hypothalamic nucleus; PLH, peduncular
part of lateral hypothalamus; PMCo, posteromedial cortical amygdaloid nucleus; PMV, premammillary nucleus, ventral part; STiA, bed nucleus of the stria terminalis,
amygdaloid division. The GM1d18:1/GM1d20:1 ratio was significantly higher within the amygdala than the hypothalamus (Mann–Whitney test, ∗∗∗∗p < 0.0001, C).
and Fujita, 2014), but also in mice (Ballesteros-Yanez et al.,
2006).
Measurements of GM1d18:1 and GM1d20:1 in the corpus
callosum and the internal capsule demonstrate that these two
major white matter regions diﬀer in lipid expression. The corpus
callosum contains mostly commissural ﬁbers that connect one
hemisphere with the other, while the long projection ﬁbers
that connect more distant brain regions with each other are
concentrated within the internal capsule. The diﬀerential GM1
proﬁle in these regions may reﬂect the diﬀerences in myelination,
as the internal capsule is myelinated earlier than the corpus
callosum and its myelin sheath is generally thinner than that of
callosal axons (Paus et al., 2001).
Among all subregions of the hippocampus included in the
present analysis, the granule cell layer of the DG demonstrated
the highest GM1d18:1/GM1d20:1 ratio. The thin subgranular
zone of the DG is one of the few locations in the mature central
nervous system where adult neurogenesis occurs. Although
we could not distinguish the subgranular zone in our mass
spectrometry images, we cannot exclude that this zone was
sampled together with the more mature GC. Having a pool of
neural stem cells and immature newborn neurons in the ROImay
inﬂuence the spectrum toward a higher GM1d18:1/GM1d20:1
ratio as immature neurons do not express notable amounts of
GM1d20:1.
An almost complementary expression of GM1d18:1 and
GM1d20:1 was seen in the molecular layer of the DG (high
GM1d20:1) versus the stratum radiatum of the CA1 and CA3
regions (high GM1d18:1). This observation mirrors what has
been reported for the mouse hippocampus previously (Sugiura
et al., 2008). As the authors of that article suggest, the high
GM1d20:1 content within the molecular layer can be explained
by projection ﬁbers from entorhinal cortex, which terminate in
this region of the DG. Using MALDI IMS, the authors show that
entorhinal cortical neurons indeed express signiﬁcant amounts
of GM1d20:1 (Sugiura et al., 2008). This is a prime example for
the fact that the GM1 content in any given region is a composite
of somatic, axonal, dendritic, and oligodendrocytic (myelin)
expression of GM1. Therefore, the GM1d18:1/GM1d20:1 ratio
has to be carefully interpreted for each anatomical region,
considering the connectivity to and from the area.
When focusing on the relative expression patterns of
GM1d18:1 and GM1d20:1visible in images, it is interesting
to note that both GM1 species are not commonly highly
expressed in the same area. Most often, either moderate
expression of both species or almost complementary expression
is observed. A pattern of expression emerges when comparing
phylogenetically older structures, such as the piriform cortex
that processes olfactory information and the hypothalamus that
controls metabolism throughout the body, with phylogenetically
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FIGURE 7 | Summary of quantification for all anatomical areas. Bar graph provides an overview of expression means for GM1d18:1/GM1d20:1 ratios across
all regions measured (A). The GM1d18:1/GM1d20:1 expression ratio is color coded for all analyzed brain regions in schematic cross sections from anterior bregma
(B) and posterior bregma (C).
younger structures such as the somatosensory cortex (Hofman,
2014; Luzzati, 2015). As organisms are known to replicate the
phylogeny of their animal species during their own development
or ontogeny (Shaw et al., 2008), it is an interesting idea that
the advent of GM1d20:1 at later stages during ontogeny may
reﬂect a more recent appearance of d20:1 ganglioside species on
the evolutionary tree. While merely speculative, this hypothesis
should be testable by analyzing d20:1 ganglioside content of
brains from evolutionarily “older” animal species such as turtles
(Northcutt, 2002).
Considerations for Interpreting MALDI
IMS Data
Using MALDI IMS, we here report a wide variety of anatomically
speciﬁc expression ratios of GM1d18:1/GM1d20:1 (Figure 7),
which likewise points toward a diﬀerential functional role of these
lipid species. When interpreting mass spectrometric data from
imaged regions, one should be mindful that GM1 ganglioside
is preferentially incorporated into lipid rafts, and therefore
the overall measured ratios in each anatomical region include
synaptic GM1. Pre-synaptic GM1may be expressed by projection
neurons from remote brain areas that synapse with resident
neurons, and post-synaptic GM1 may include dendrites from
neighboring neurons that reach into the ROI where the GM1
ratio was measured. Therefore, the GM1d18:1/GM1d20:1 ratio
measured in these areas does not necessarily reﬂect the expression
proﬁle of resident neurons.
Another limitation of MALDI IMS that has to be kept in
mind is that molecular images acquired at this resolution do
not allow discrimination of cytoarchitectonic features. Such
cytoarchitectonic features clearly delineate borders between
diﬀerent anatomical regions, including cortical subregions
(Brodmann, 1909). As a consequence of this limitation, we
rely on the Rat Brain Atlas by Paxinos and Watson (1998) for
identiﬁcation of ROIs.
A diﬀerent consideration has to be taken into account as
well when using MALDI IMS. One of the limitations of this
technique is that each mass spectrum obtained from individual
images is unique in signal intensity and signal to noise ratio
based on slight diﬀerences in tissue properties, tissue harvest and
preparation, matrix application, and other inevitable variables
(Heeren et al., 2009). Therefore, absolute quantiﬁcation requires
reference to concentration standards spotted on the tissue, which
is increasingly being explored for exogenous compounds such
as drugs (Nilsson et al., 2010; Lietz et al., 2013). Because we are
measuring endogenous molecules, we can quantify expression
of gangliosides by relating either one peak to a diﬀerent peak
in the same spectrum, as done in the present work, or by
relating an individual peak in one anatomical area to the
corresponding peak in a diﬀerent anatomical area within the
same image (Caughlin et al., 2015). Thus, the sample-to-sample
variations in IMS signal intensity due to sample preparation
and instrumentation should be canceled out by reporting
ratios of GM1d18:1/GM1d20:1 expression rather than absolute
measures of expression. Absolute quantiﬁcation of GM1 species
using MALDI IMS is additionally confounded by potential
sialic acid breakdown from polysialylated gangliosides such as
GD1, GT1, and GQ1, a process that increases the signal of the
monosialylated GM1 (Ivleva et al., 2004).
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CONCLUSION AND OUTLOOK
Matrix-assisted laser desorption/ionization IMS allows us to
discover new, potentially meaningful insights into the chemical
make-up of the brain. The tight regulation of expression of
GM1d18:1 and GM1d20:1 in anatomically distinct regions as
described here points toward diﬀerential functional properties of
these two species. With novel technologies and instrumentation
at hand, investigations into the expression of gangliosides with
diﬀerence ceramide moieties in pathological conditions will help
elucidate what role these molecules play in injury, in disease and
for the challenges faced by the aging brain.
Based on the distinct anatomical expression pattern reported
here, questions arise as to how expression of GM1d20:1 and
GM1d18:1 is so tightly regulated. Elucidation of the genetic and
enzymatic control of expression may advance our understanding
of these molecules greatly. Speciﬁcally, taking into account
the increase of GM1d20:1 expression during development,
GM1d20:1 may play a unique role in higher order brain
functions. In addition, elucidating the expression pattern of
GM1d20:1 in the aging brain may help understand whether
this molecule may be involved in making the aging brain more
vulnerable to degenerative challenges.
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